Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme

By sjmartinez • February 1, 2023

Dougados M, Charles-Schoeman C, Szekanecz Z, Giles JT, Ytterberg SR, Bhatt DL, Koch GG, Vranic I, Wu J, Wang C, Kwok K, Menon S, Connell CA, Yndestad A, Rivas JL, Buch MH. Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme. Ann Rheum Dis. 2023 Jan 31:ard-2022-223406. doi: 10.1136/ard-2022-223406. Epub ahead of print. PMID: 36720582.

Tags: Antirheumatic Agents, Arthritis, cardiovascular diseases, Publications, Rheumatoid, Rheumatology

Assessment of Seroprevalence and Neutralizing Antibodies for Healthcare Worker Protection in a Crimean-Congo Hemorrhagic Fever Endemic Area

Pınarlık F, Karaşahin Ö, Yanık A, Akça D, Sarıkaya Rİ, Güllü D, Arslan EN, Yalçın S, Barlas T, Can FK, Alay H, Özden K, Kuşkucu[...]

Hypertrophic Cardiomyopathy with Left Ventricular Systolic Dysfunction: Integrating Pharmacologic, Device, and Advanced Heart Failure Therapies

Tajdini M, Tavakoli K, Jenkin SC, Keykhaei M, Hahn VS. Hypertrophic Cardiomyopathy with Left Ventricular Systolic Dysfunction: Integrating Pharmacologic, Device, and Advanced Heart Failure Therapies.[...]

Dental malocclusion and associated factors in pet rabbits: a cross-sectional study in Peru (2021-2022)

Masias K, Tejada A, Segura ER, Ormea V. Dental malocclusion and associated factors in pet rabbits: a cross-sectional study in Peru (2021-2022). N Z Vet[...]